20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T12404 | CCK-A receptor inhibitor 1 | cholecystokinin | |
CCK-A receptor inhibitor 1 is a potent inhibitor of the cholecystokinin A (CCK-A) receptor (IC50: 340 nM).CCK-A receptor inhibitor 1 can be used for the study of diseases related to the digestive system. | |||
T13261 | CCK-B Receptor Antagonist 1 | Others | |
CCK-B Receptor Antagonist 1 is a cholecystokinin B (CCK-B) receptor agonist and has the potential of reducing the secretion of gastric acid. | |||
T10707 | CCK-B Receptor Antagonist 2 | Others | |
CCK-B Receptor Antagonist 2 is a potent and orally active antagonist of Gastrin/CCK-B (IC50: 0.43 nM). It also inhibits gastrin/CCK-A activity (IC50: 1.82 μM). | |||
TP1197 | Sincalide | SQ19844,CCK-8,Cholecystokinin octapeptide | Others |
Sincalide (CCK-8) is a cholecystokinetic drug administered by injection to aid in diagnosing disorders of the gallbladder and pancreas. It is the 8-amino acid C-terminal fragment of cholecystokinin. | |||
T1052 | Proglumide | cholecystokinin | |
Proglumide (Binoside) is a cholecystokinin antagonist, which blocks both the CCKA and CCKB subtypes. Proglumide is a drug that exerts an inhibitory effect on gastric secretion and reduces gastrointestinal motility. It is... | |||
TQ0062 | Nastorazepide | Z-360 | cholecystokinin |
Nastorazepide (Z-360) is a selective, orally available antagonist of gastrin/cholecystokinin 2 (CCK-2) receptor with potential antineoplastic activity. | |||
T2312 | Loxiglumide | CR-1505 | cholecystokinin |
Loxiglumide (CR-1505) is an antagonist of cholecystokinin (CCK-1) receptor. | |||
T4579 | Pentagastrin | ICI-50123 | Others , cholecystokinin |
Pentagastrin (ICI-50123) is a synthetic polypeptide that has effects like gastrin when given parenterally, which can cause the secretion and synthesis of salivary proteins. | |||
T14932 | Ceruletide | Cerulein,Caerulein,FI-6934 | cholecystokinin |
Ceruletide (Caerulein) is a potent agonist of cholecystokinin receptor and it also is a safe and effective cholecystokinetic agent. It has a direct spasmogenic effect on the gallbladder muscle and bile ducts. | |||
T9343 | N-Cbz-DL-tryptophan | cholecystokinin | |
N-Cbz-DL-tryptophan is a cholecystokinin receptor antagonist, abolished the response of the isolated heart to CCK-8. | |||
T14932L | Ceruletide Ammonium acetate | FI-6934 Ammonium acetate,Caerulein Ammonium acetate,Ceruletide Ammonium acetate (17650-98-5 free base) | cholecystokinin |
Ceruletide Ammonium acetate (FI-6934 Ammonium acetate) is a cholecystokinin (CCK) receptor agonist. Ceruletide Ammonium acetate is a safe and effective cholecystokinetic agent and small bowel and exocrine pancreatic stim... | |||
TP1931L1 | [D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P acetate | [D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P acetate(96736-12-8 free base) | cholecystokinin |
[D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P acetate ([D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P acetate (96736-12-8 free base)) is a broad spectrum neuropeptide inverse agonist and antagonist. Potent full inverse agonist ... | |||
T15101 | Devazepide | L-364,718,MK-329 | Others |
Devazepide is a competitive and orally active nonpeptide antagonist of cholecystokinin (CCK) receptor (IC50s: 81 pM, 45 pM, and 245 nM for rat pancreatic, bovine gallbladder and guinea pig brain CCK receptors, respective... | |||
T28340 | PD-135666 | PD 135666 | |
PD-135666 is an antagonist of CCK receptor. | |||
T26483 | A-65186 | A65186 | |
A 65186 is a Type A Cholecystokinin (CCK) receptor antagonist. | |||
T23886 | Cholecystokinin (27-32)-amide | Cholecystokinin (27-32)-NH2 | |
Cholecystokinin (27-32)-amide is a CCK receptor antagonist. | |||
T22666 | CI-988 | CI 988 | Others |
CCK2 (CCK-B) receptor antagonist | |||
T13084 | Tarazepide | Others | |
Tarazepide is a potent and specific antagonist of CCK-A receptor. | |||
T27014 | CI-1015 | CI1015,CI 1015,PD 144598 | |
CI-1015 is a CCK-B receptor antagonist with oral activity. | |||
T29502 | A 70874 | A-70874,A70874 | |
A70874 has high selectivity and potency for cholecystokinin (CCK) a receptor. |